Skip to main content
SpringerLink
Log in
Book cover

Die Onkologie pp 973–981Cite as

Gallenblasen- und Gallengangskarzinom

  • Chapter

Zusammenfassung

Die Karzinome der Gallenblase und der extrahepatischen Gallenwege zählen mit 0,5–1% aller Neoplasien zu den seltenen malignen Erkrankungen. Aufgrund der unspezifischen Symptomatik und der Tatsache, dass potentiell kurable Tumoren mithilfe bildgebender Verfahren oft nicht dargestellt werden können, sowie fehlender effektiver systemischer Therapiemodalitäten, beträgt die Fünfjahresüberlebensrateetwa 5%. Die Inzidenz der Gallenblasen-/Gallengangskarzinome entspricht daher ungefähr der Mortalitätsrate. Jährlich erkranken weltweit etwa 2–3/100.000 an einem Karzinom der Gallenblase/-wege. Gehäuftes Auftreten wird in Israel mit einer Inzidenz von 13/100.000 pro Jahr sowie in Mexiko, Bolivien und Chile beobachtet. Die Wahrscheinlichkeit an einem Karzinom der Gallenblase/-gänge zu erkranken ist bis zum 4. Lebensjahrzehnt eher gering und steigt ab dem 6. Lebensjahrzehnt deutlich an, wobei der Altersgipfel zwischen dem 5. und 7. Lebensjahrzehnt liegt. Das Gallenblasenkarzinom wird häufiger bei Frauen diagnostiziert (Geschlechtsverhältnis 3:1), während das Gallengangskarzinom eher beim Mann auftritt (Geschlechtsverhältnis 2:1).

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Abu-Elmagd KM, Selby R, Iwatsuki S (1993) Cholangiocarcinoma and sclerosing cholangitis: clinical characteristics and effect on survival after liver transplantation.Transplat Proc 25: 11–25

    Google Scholar 

  • Andre T, Louvet C, Artru P et al. (2001) A phase II study of gemcitabine and oxaliplatin (gemox) in advanced biliary adenocarcinoma: Preliminary results. Eur J Cancer 37 [Suppl 6]: 19

    Article  Google Scholar 

  • Akwari OE, van Heerden JA, Foulk WT, Baggenstoss AK (1975) Cancer of the bile ducts associated with ulcerative colitis. Ann Surg 181: 303–309

    Article  PubMed  CAS  Google Scholar 

  • Baer HU, Stain SC, Dennison AR, Eggers B, Blumgart LH (1993) Improvements in survival by aggressive resections of hilar cholangiocarcinoma.Ann Surg 217: 20–27

    CAS  Google Scholar 

  • Chow NH, Huang SM, Chan SH, Mo LR, Hwang MH, Su WC (1995) Significance of c-erbB-2 expression in normal and neoplastic epithelium of the biliary tract. Anticancer Res 15: 1055–1059

    PubMed  CAS  Google Scholar 

  • Cubertafond P, Gainant A, Cucchiaro G (1994) Surgical treatment of 714 carcinomas of the gallbladder results of the frech surgical association survey. Ann Surg 219: 275–280

    Article  PubMed  CAS  Google Scholar 

  • Goldstein RM, Stone M, Tiller W, Senzer N, Levy M, Husberg BS, Gonwa T, Klintmalm G (1993) Is liver transplantation indicated for cholangiocarcinoma? Amer J Surg 166: 768–772

    Article  PubMed  CAS  Google Scholar 

  • Haswell-Elkins MR, Satarug S, Alkins DB (1992) Opisthorchis viverrini infection in NortheastThailand and its relationship to cholangiocarcinoma. J Gastroenterol Hepatol 7: 538

    Article  PubMed  CAS  Google Scholar 

  • Hejna M, Pruckmayer M, Raderer M (1998) The role of chemotherapy and radiation in the management of biliary tract cancer:a review of the literatur. Europ J Cancer 34: 977–986

    Article  CAS  Google Scholar 

  • Kornek GC, Schmidt K, Schüll B et al. (2002) Mitomycin C in combination with capecitabine or biweekly high dose gemcitabine in patients with advanced biliary tract cancer. Ann Oncol 13 [Suppl 4]:Abstr 725

    Google Scholar 

  • Kraybill WG, Lee H, Picus J, Ramachandran G, Lopez MJ, Kucik N, Myerson RJ (1994) Multidisciplinary treatment of biliary tract cancers. J Surg On-col 55: 239–245

    CAS  Google Scholar 

  • Kuhn R, Ridwelski K, Eichelmann K et al. (2001) Outpatient combination chemotherapy with gemcitabine and docetaxel in patients with cancer of the biliary system. Proc Am Soc Clin Oncol 20: A2272

    Google Scholar 

  • Lee CS (1997) Ras p21 protein immunoreactivity and its relationship to p53 expression and prognosis in gallbladder and extrahepatic biliary carcinoma. Eur J Surg Oncol 23: 233–237

    Article  PubMed  CAS  Google Scholar 

  • Lowenfels AB (1982) Gallstones and the risk of cancer. Gut 21: 1090–1092

    Article  Google Scholar 

  • Minsky BD, Kemeny N, Armstrong JG, Reichmann B, Botet J (1991) Extrahepatic biliary system cancer; an update of a combined modality approach.Am J Clin Oncol 14: 433–437

    CAS  Google Scholar 

  • Nevin JE, Moran TJ, Kay S, King R (1988) Carcinoma of the gallbladder. Cancer 37: 141–148

    Article  Google Scholar 

  • O’Grady JG, Poison RJ, Rolles K, Caine RY, Williams R (1988) Liver transplantation for malignant disease. Ann Surg 207: 373–379

    Article  PubMed  Google Scholar 

  • Oberfield RA, Rossi RL (1988) The role chemotherapy in the treatment of bile duct cancer. World J Surgery 12: 105–108

    Article  CAS  Google Scholar 

  • Pitt HA, Dooley WC, Yeo CJ, Cameron JL (1995) Malignancies of the biliary tree.Curr Probl Surg 32: 1–90

    Article  CAS  Google Scholar 

  • Raderer M, Heja M, Valencak J et al. (1999) Two consecutive phase II studies of 5-fluorouracil, leukovorin and mitomycin C and of gemcitabine in patients with advanced biliary cancer. Oncology 56: 177–180

    Article  PubMed  CAS  Google Scholar 

  • Remmele W (1996) Leber, Gallenblase, extrahepatische Gallenwege,VaterPapille, exokrines Pankreas, Peritoneum, Retroperitoneum, Hernien, Atemwege and Lungen, Pleura. In: Remmele w (Hrsg) Pathologie, 2. Aufl. Springer, Berlin Heidelberg New York Tokyo

    Google Scholar 

  • Ringe B, Wittekind C, Bechstein WO, Bunzendahl H, Pichlamayr R (1988)The role of liver transplantation in hepatobiliary malignancy. Ann Surg 209: 88–98

    Google Scholar 

  • Scheithauer W (2002) Review of gemcitabine in biliary tract carcinoma. Semin Oncol 29 [Suppl 20]: 40–45

    PubMed  CAS  Google Scholar 

  • Sumiyoshi K, Nagai E, Chijiiwa K, Nakayama F (1991) Pathology of carcinoma of the gallbladder.World J Surg 15: 315–321

    Article  CAS  Google Scholar 

  • Tanaka K, Nishimura A, Yamada K, Ishibe R, Ishizaki N, Yoshimine M, Ramada N, Taira A (1993) Cancer of the gallbladder associated with anomalous junction of the pancreatobiliary duct system without bile duct dilatation. Brit J Surg 80: 622–624

    Article  PubMed  CAS  Google Scholar 

  • Temporo M, Hansen S, Enke C et al. (1995) Chemoradiotherapy followed by orthotopic liver transplantation for unresectable cholangiocellular carcinoma. Am Soc Clin Oncol 14: 449

    Google Scholar 

  • Voyles CR, Smadja C, Shands WC, Blumgart LH (1983) Carcinoma in choledochal cyst:age-related incidence. Arch Surg 118: 986–988

    Article  PubMed  CAS  Google Scholar 

  • Washington K, Gottfried MR (1996) Expression of p53 in adenocarcinoma of the gallbladder and bile ducts. Liver 16: 99–104

    Article  PubMed  CAS  Google Scholar 

  • Williams SM, Harned RK (1981) Bile duct carcinoma associated with chronic ulcerative colitis. Dis Colon Rectum 24: 42–44

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. G. Kornek
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Kornek, G. (2004). Gallenblasen- und Gallengangskarzinom. In: Die Onkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-06670-6_41

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-06670-6_41

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-06671-3

  • Online ISBN: 978-3-662-06670-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation